Benefits and Side Effects of Empliciti Elotuzumab Injection

Empliciti Elotuzumab injection is a medication used to treat multiple myeloma. While it is effective in curing this type of cancer, it can cause side effects. In fact, some patients have reported early death and the occurrence of new cancers. Therefore, patients should consult with a doctor before starting the treatment


.


EMPLICITI is used to treat multiple myeloma

The Empliciti Elotuzumab injection is an immunotherapy drug used to treat multiple myelomoma. It comes in a single-dose vial and is given as an intravenous (IV) infusion. The length of the infusion depends on the amount of the drug in the vial and the body weight of the patient. It is important to discuss the dosage with your healthcare provider, since different dosages will work for different people.

It can cause side effects

Empliciti Elotuzumab injection is an immunotherapy that targets the hepatic stellate cell antigen receptor. During the injection, patients may experience various side effects. These effects may include hepatotoxicity, elevated total bilirubin levels, and elevated alkaline phosphatase levels. Some of these side effects may be transient, and some patients may experience them only once. Other symptoms include dizziness, headache, chest pain, and fever.

It can cause early death in people with MCL

The Empliciti Elotuzumab injection  is an investigational monoclonal antibody that binds to multiple myeloma cells and activates the immune system. By doing so, Empliciti helps the immune system detect and destroy the cancer cells. It is available in two strengths, 300 mg and 400 mg, and is given via an intravenous infusion. The injection takes about one hour to complete.

It can cause new cancers

It is important to remember that Empliciti Elotuzumab injection should only be administered in a single dose. It must be administered within 24 hours after reconstitution. The infusion solution should be refrigerated and protected from light for up to 24 hours. It can be stored at room temperature or in a refrigerator for up to eight hours. It should not be stored in a freezer.

It is a biologic drug

Empliciti Elotuzumab injection is a humanized recombinant monoclonal antibody directed against SLAMF7, a glycoprotein found on the cell surface. Developed using recombinant DNA technology, it consists of the mouse antibody MuLuc63 fused to a human IgG1 heavy chain. The final product has a theoretical mass of 148.1 kDa and is available in lyophilized powder form. The dose of the drug is 300 or 400 mg per vial.

Comments

Post a Comment

Popular posts from this blog

What Is IDHIFA (Enasidenib)? Causes, Side Effects, Dosage

Image
  WHAT IS IDHIFA (Enasidenib)? IDHIFA Medicine IDHIFA is a prescription medicine used to treat people with acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mutation whose disease has come back or has not improved after previous treatment(s). It is not known if IDHIFA is safe and effective in children. IDHIFA may cause serious side effects, including: Differentiation Syndrome. Differentiation syndrome is a condition that affects your blood cells which may be life-threatening or lead to death if not treated. Differentiation syndrome has happened within 1 day and up to 5 months after starting IDHIFA. Check the following symptoms below. ·          fever ·          cough ·          shortness of breath ·          swelling of arms and legs ·          fast weight gain (greater than 10 pounds within a week) ·          bone pain If you develop any of these symptoms of differentiation syndrome, your healthcare provider may start you on a medicine taken by m
Read more

Hunter Syndrome is Very Rare | Named Patient Program in India

Image
  Hunter Syndrome is an extremely uncommon, acquired hereditary problem brought about by an absent or breaking down compound. In Hunter disorder, the body needs more of the compound iduronate 2-sulfatase. This present compound's responsibility is to separate specific complex particles, and without enough of this protein, the atoms develop in unsafe sums.  The development of enormous measures of these unsafe substances in the long run causes long-lasting, moderate harm influencing appearance, mental turn of events, organ work and actual capacities. Hunter Syndrome is undeniably more normal in young men. The condition is one kind of a gathering of acquired metabolic issues called mucopolysaccharidoses (MPSs). Tracker condition is otherwise called MPS II. Import Elaprase (idursulfase) medicine under named patient program which is commonly use for hunter syndrome.  There's no remedy for Hunter disorder. Treatment includes overseeing side effects and difficulties. Side effects Syndr
Read more

Glyxambi (empagliflozin and linagliptin) Medicine - Uses, Precautions, Indications

Image
What is Glyxambi? Glyxambi (empagliflozin and linagliptin) is a combination of an inhibitor of the sodium-glucose co-transporter (SGLT2) and an inhibitor of the dipeptidyl peptidase-4 (DPP-4) enzyme as an adjunct to diet and exercise to improve glycemic control. What are the side effects of Glyxambi? Common side effects of Glyxambi include: • urinary tract infection • Common cold symptoms • Upper respiratory tract infection • Genital Yeast Infection • Increased urination • Joint pain • Nausea • runny or stuffy nose • Diarrhea • cough • Elevated blood cholesterol or fat • Diarrhea Glyxambi Dosage The recommended dose of Glyxambi is 10 mg empagliflozin/5 mg linagliptin, taken once daily in the morning, with or without food. In patients who tolerate Glyxambi, the dose may be increased to 25 mg empagliflozin/5 mg linagliptin once daily. Do drugs, substances, or supplements interact with Glyxambi? Glyxambi during pregnancy and lactation During pregnancy
Read more